Bristol-Myers Squibb's flurry of dealmaking has continued with en expansion of its partnership with BridgeBio on drugs targeting SHP2, in the hope of combining them with its cancer immunotherapy ...
Bristol-Myers Squibb has formed an R&D partnership with GentiBio, aimed at developing regulatory T cel (Treg) therapies for inflammatory bowel disease (IBD). The deal includes an undisclosed upfront ...
New students join the Bentley community in both the fall and spring semesters. Regardless of when you start, you will have a robust New Falcon Experience. Along the way, there are tasks that you will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results